PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM UMR1152, Laboratoire d\'Excellence Inflamex, Faculté de Médecine, Hôpital Bichat, Université de Paris, Paris, France.\', \'Sorbonne Université, INSERM UMR S 938, Centre de Recherche Saint-Antoine (CRSA), Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.01229
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32574272
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
?:type

Metadata

Anon_0  
expand all